Professor of Medicine, Brown University
Nephrology
Dr. Lance D. Dworkin, MD
|
|
Give Review
Lance Dworkin works in the field of Nephrology. He went to Perelman School of Medicine at the University of Pennsylvania. He over the years received 4 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACP)" and "Fellow (ASNF)". Doctor Lance D. Dworkin, MD is a published doctor. He published 102 publications, including: 'Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.' Doctor Lance D. Dworkin, MD is registered with Medicare and accepts Medicare payments.
Publications
- Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of Renal donor...
- Use of Renin-Angiotensin Inhibitors in People With Renal Artery Stenosis.
- The Glomerulus: The Sphere of Influence.
- Roll-in Experience from the Cardiovascular Outcomes With Renal Atherosclerotic Lesions (CORAL) Study.
- Stenting and medical therapy for atherosclerotic Renal-artery stenosis.
- Genetic or Pharmacologic Blockade of EGFR Inhibits Renal Fibrosis.
- Inhibition of glycogen synthase kinase-3? prevents NSAID-induced Acute kidney injury.
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early Acute kidney injury.
- Conditional ablation of glycogen synthase kinase 3β in postnatal mouse Kidney.
- A novel STAT3 inhibitor, S3I-201, attenuates Renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
- Is there any reason to stent atherosclerotic Renal artery stenosis?
- Lei-Shi Li: a giant in international nephrology.
- Direct Fibrogenic Effects of Aldosterone on Normotensive Kidney: An Effect Modified by 11{beta}-HSD Activity.
- Clinical practice. Renal-artery stenosis.
- Candesartan suppresses Chronic renal inflammation by a novel antioxidant action independent of AT1R blockade.
- Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in Renal tubular epithelial cells.
- Long-term, high-dosage candesartan suppresses inflammation and injury in chronic Kidney disease: nonhemodynamic renal protection.
- Is Renal artery stenting the correct treatment of Renal artery stenosis? Case against angioplasty and stenting of atherosclerotic Renal artery stenosis.
- Controversial treatment of atherosclerotic renal vascular Disease: the cardiovascular outcomes in renal atherosclerotic lesions trial.
- Anti-inflammatory effect of hepatocyte growth factor in chronic Kidney disease: targeting the inflamed vascular endothelium.
- The Cardiovascular Outcomes With Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.
- Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in Renal tubular epithelial cells.
- Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate.
- Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant Kidney by modulating tubular expression of macrophage chemoattractant protein-1 and...
- Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats With established renal injury.
- Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive Renal interstitial fibrosis.
- Effects of intravenous essential L-amino acids and hypertonic dextrose on anephric beagles.
- Interferon alpha selectively affects expression of the human myeloid cell nuclear differentiation antigen in late stage cells in the monocytic but not the granulocytic...
- Acute renal failure and the MELAS syndrome, a mitochondrial encephalomyopathy.
- Elevated fasting total plasma homocysteine levels and cardiovascular Disease outcomes in maintenance dialysis patients. A prospective study.
- Lower fasting total plasma homocysteine levels in stable Renal transplant recipients versus maintenance dialysis patients.
- A functional fibroblast growth factor-1 immunoglobulin fusion protein.
- Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients With a normal serum creatinine.
- Short-term reproducibility of total homocysteine determinations in stable Renal transplant recipients.
- Determinants of fasting plasma total homocysteine levels among Chronic stable renal transplant recipients.
- Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery Disease patients after fortification of cereal grain flour with folic acid.
- Plasma total homocysteine and hemodialysis access thrombosis: a prospective study.
- Improving clinician acceptance and use of computerized documentation of coded diagnosis.
- Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- Treatment of mild hyperhomocysteinemia in Renal transplant recipients versus hemodialysis patients.
- Treatment of hyperhomocysteinemia in hemodialysis patients and Renal transplant recipients.
- Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
- Renal production of hepatocyte growth factor increases after unilateral nephrectomy in man.
- Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Wor...
- Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears.
- Combined tricuspid and pulmonic stenosis. Clinical, echocardiographic, hemodynamic, surgical, and pathological features.
- The utility of 6-month protocol Renal biopsy under modern immunosuppression.
- Efficacy and safety of renal tubule cell therapy for Acute renal failure.
- Comparison of plasma clearance of iodixanol during versus after angiography.
- Incidence of hyperkalemia in high risk patients during treatment With an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker...
- Stent revascularization for the prevention of cardiovascular and renal events among patients With renal artery stenosis and systolic hypertension: rationale and design...
- Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk Kidney transplant recipients.
- Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid.
- Increase urinary hepatocyte growth factor excretion in human Acute renal failure.
- Na+/H+ exchanger isoform 2 (NHE2) is expressed in the apical membrane of the medullary thick ascending limb.
- Sodium balance in renal Failure.
- Impact of antihypertensive therapy on progression of experimental renal Disease.
- In vivo and in vitro evidence for increased expression of HGF receptor in Kidney of diabetic rat.
- Calcium antagonists in the treatment of hypertension: special clinical considerations.
- Update in nephrology.
- Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells.
- Salt restriction inhibits renal growth and stabilizes injury in rats with established renal Disease.
- Effects of amlodipine on glomerular filtration, growth, and injury in experimental Hypertension.
- Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
- Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy.
- Cardiorenal hemodynamics and sodium excretion in rats With myocardial infarction.
- Hormonal influences on glomerular function.
- Hemodynamic basis for glomerular injury in rats With desoxycorticosterone-salt hypertension.
- Hormonal modulation of glomerular function.
- Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary Hypertension.
- Glomerular Hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy.
- Pathogenesis of systemic Hypertension and glomerular injury in the spontaneously hypertensive rat.
- Impact of antihypertensive therapy on progressive Kidney damage.
- Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.
- Glomerular size-selective barrier dysfunction in nephrotoxic serum nephritis.
- Calcium carbonate exacerbates glomerular capillary hypertension and injury in rats with desoxycorticosterone-salt hypertension.
- Impact of Calcium entry blockers on glomerular injury in experimental hypertension.
- Effects of nifedipine and enalapril on glomerular injury in rats With deoxycorticosterone-salt hypertension.
- Superiority of salt restriction over diuretics in reducing Renal hypertrophy and injury in uninephrectomized SHR.
- Renal vascular effects of Calcium channel blockers in hypertension.
- Effects of Calcium antagonists on glomerular hemodynamics and structure in experimental hypertension.
- Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.
- Why Kidneys fail.
- Does essential hypertension cause end-stage renal Disease?
- Effects of salt restriction on renal growth and glomerular injury in rats with remnant Kidneys.
- Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition.
- Onset of glomerular hypertension With aging precedes injury in the spontaneously hypertensive rat.
- Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in Acute renal failure.
- Current strategies for management of hypertensive renal Disease.
- Clinical outcome in three patients With postpartum hemolytic uremic syndrome treated With frequent plasma exchange.
- Expression of Na+/H+ exchanger isoforms in inner segment of inner medullary collecting duct.
- Antihypertensive drugs, dietary salt, and renal protection: how low should you go and With which therapy?
- Constitutive expression of HGF modulates Renal epithelial cell phenotype and induces c-met and fibronectin expression.
- Hepatocyte growth factor protects Renal epithelial cells from apoptotic cell death.
- AntiHypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
- Genomic approaches to elucidating the pathophysiology of renal Diseases.
- Serum cystatin C as a marker of glomerular filtration rate.
- Residual Renal function and mortality risk in hemodialysis patients.
- Endogenous hepatocyte growth factor ameliorates Chronic renal injury by activating matrix degradation pathways.
- Antihypertensive therapy and progression of Chronic renal disease.
- The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.
Schools
University Of Pennsylvania School Of Medicine
Bellevue Nyu
Harvard Brigham Womens Hospital
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Fellow (ASNF)
Education
-
Brigham and Women's Hospital -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Rhode Island Hospital
Drug Facts
| NPI NUMBER | 1053358770 | |
| NPPES Provider LastName | DWORKIN | |
| NPPES Provider FirstName | LANCE | |
| NPPES Provider ZIPCode | 029034923 | |
| NPPES Provider State | RI | |
| Specialty Description | Nephrology | |
| Total Claim Count | 235.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053358770 |
| Last Name Of The Provider | DWORKIN |
| First Name Of The Provider | LANCE |
| View All |
Similar Doctors
|
|
Dr. Adam M. Goldstein, MD |
|
|
Dr. Andreea Poenariu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mariana Murea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric S. Kerns, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayman M. Wahbeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Shorter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. O'Bell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fahmeedah S. Kamal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J Gary Abuelo, MD |
|
|
Dr. Jaime S. Carvalho, MD |
|
|
Dr. David C. Yoburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Cottiero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey D. Clement, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc S. Weinberg, MD
This Doctor is OpenDoctor Recommended.
|